American Bio Medica (ABMC) Return on Assets ROA from the first quarter of 2023 to first quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
American Bio Medica Corporation  (ABMC)


American Bio Medica's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is American Bio Medica's ROA in the first quarter of 2023?
American Bio Medica Corporation achieved a return on average assets (ROA) of 71.35 % in its first quarter of 2023, this is above ABMC's average return on assets of -23.99%.
American Bio Medica Corporation assets over the 12 months ending in its first quarter of 2023 are valued at $1 million

ROA has improved compared to -103.13% in the fourth quarter of 2022, due to net income growth.

However, within the Healthcare sector 12 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2023 quarter, so far to 50, from total ROA ranking in the fourth quarter of 2022 at 5988.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Total Assets Change -44.98 % -35.57 % -48.26 % -23.6 % -11.43 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 1 -1 -1 0 0
Return On Assets (TTM) 71.35 % -103.13 % -90.3 % -23.91 % -14.73 %
ABMC's Total Ranking # 50 # 5988 # 5252 # 4493 # 4208
Total Assets (TTM) in million 1 1 1 1 2
Seq. Total Assets Change -41.47 % 24.98 % -6.29 % -19.74 % -31.45 %
Seq. Net Income Change - - - - -

ABMC's 5 Years Annual ROA >> Back to ABMC Management Effectiveness >> Compare ABMC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 8
Sector # 13
Overall # 47

Return On Assets Statistics
High Average Low
77.96 %
-23.99 %
-107.08 %
(Mar 31 2023)   (Dec 31 2022)





Financial Statements
American Bio Medica's Assets $ 1 million ABMC's Balance sheet
American Bio Medica's Income $ 2 million Quarterly ABMC's Income Statement
ABMC's Income by Division See ABMC's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change -32.61 % -2.23 % -7.31 % -16.04 % -14.39 %
Total Assets in million 1 2 2 2 2
Y / Y Net Income Change - - - - -
Net Income in million -1 0 -1 -1 -1
Annual Return On Assets -111.11 % -24.59 % -41.33 % -32.77 % -41.54 %

ABMC's 5 Years Annual ROA >> Back to ABMC Management Effectiveness >> Compare ABMC ROA to its Competitors



More Return On Assets Ratios
ABMC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ABMC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ABMC's Competitors
Subscribers only: Roa for American Bio Medica's Suppliers
Subscribers only: Return On Assets for ABMC's Customers

You may also want to know
ABMC's Roi ABMC's Inventory Turnover Ratio ABMC's Growth Rates ABMC's Dividend Comparisons
ABMC's Profitability Ratios ABMC's Asset Turnover Ratio ABMC's Dividend Growth
ABMC's Roe ABMC's Valuation Ratios ABMC's Financial Strength Ratios ABMC's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2023, within Healthcare Sector ROA
Theravance Biopharma inc   154.35 %
Gyre Therapeutics Inc   154.03 %
Ir med Inc   146.61 %
Therapeuticsmd Inc   146.38 %
Biocorrx Inc   117.63 %
Talphera Inc   96.59 %
Chimerix Inc   79.32 %
American Bio Medica Corporation  77.96 %
Tff Pharmaceuticals Inc  75.62 %
Molecular Templates Inc   75.26 %
Gamida Cell Ltd   70.21 %
Opus Genetics Inc   58.94 %
Biomx Inc  53.77 %
Aptevo Therapeutics Inc   52.97 %
Kiniksa Pharmaceuticals International Plc  49.92 %
Dariohealth Corp   47.79 %
Voyager Therapeutics Inc   45.67 %
Shockwave Medical Inc   41.44 %
Intercept Pharmaceuticals inc   39.13 %
Zymeworks Inc   35.99 %
Avalo Therapeutics Inc   34.89 %
Harmony Biosciences Holdings inc   29.87 %
Catalyst Pharmaceuticals Inc   28.75 %
Arcturus Therapeutics Holdings Inc   28.68 %
Assertio Holdings inc   26.35 %
Idexx Laboratories Inc  25.89 %
Semler Scientific inc   25.34 %
Mettler toledo International Inc   23.93 %
Dynavax Technologies Corporation  23.70 %
Point Biopharma Global Inc   23.14 %

Date modified: 2026-09-08T15:10:58+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.